EuroEspes S.A. is a Spanish medical center and biotechnology company specializing in personalized genomic medicine, with a primary focus on neuroscience and central nervous system disorders. It serves as an international reference center for the research, diagnosis, and treatment of neurological conditions such as Alzheimer's and Parkinson's diseases, alongside prevention programs for prevalent age-related pathologies including cardiovascular diseases, cancer, and metabolic disorders. The company offers comprehensive services like the Alzheimer Prevention Plan, genomic and epigenetic testing for predictive diagnostics, clinical assessments, neuropsychological evaluations, and personalized pharmacogenetic protocols conducted in a single-day protocol for efficiency. Through its biotechnology segment, EuroEspes S.A. develops and distributes nutraceutical bioproducts derived from marine species and plant extracts to support wellness. Operating in the healthcare sector, it emphasizes cutting-edge approaches in genomics, epigenetics, transcriptomics, proteomics, and metabolomics to enable proactive prevention and tailored therapies. Founded in 1991 and headquartered in Bergondo, Spain, EuroEspes S.A. leads in Spain's genomic medicine landscape, integrating advanced research with clinical practice.